Never Give Up
Collecting improvements, until there's a cure.
- Messages
- 971
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
“The thing I found fascinating, and this still appears to be the case, is we tend to underfund things where we blame the victim,” Johnston said.
Which is another reason why psychobabblers and the myths they perpetuate are so harmful to us.
That might be shocking - a 3x discrepancy - but for mecfs the situation is even worse, we get about 25x less than rheumatoid arthritis, 50x less than MS (someone might want to check my figures)Two diseases with a similar health burden, breast cancer and chronic liver disease, received wildly different levels of support: $763 million for the cancer best known for iconic pink ribbon awareness efforts, versus $284 million for a disease commonly caused by alcohol abuse.
Which suggests that the NIH are beginning to take this issue more seriously. Maybe they will be more sympathetic to mecfs as a result? I don't know, but that's exactly the case that Brian Vastag was making in his appeal to NIH director Francis Collins - this disease is hopelessly underfunded when you look at the disease burdern (and the cost to the economy).[NIH Assoc Director for Science Policy, Dr Carrie[] Wolinetz said this is the first time that NIH has put out its own analysis of the breakdown of research funding versus burden of disease, a signal of transparency that many outside researchers applauded.
Thomas Insel, the director of the [NIH mental health] institute, said he found the analysis [on disease burden] illuminating. It led to an increased focus on suicide and eating disorders.
"When we did it internally, it became really clear that an area that was really underfunded was suicide research," Insel said. "I just really didn’t realize that. I thought we had a lot more invested there. I should have known. I should have figured it out some other way, but it wasn’t until I saw the graph that I realize that was an area we needed to build."
The "DALY" disease burden figures in that graph are per disease overall (not per patient), factoring in prevalence as well as 'lost years' lost through both disability and premature death. Hence my 25x versus MS. Maybe MS isn't the ideal comparison, but it's one I've seen cited before (and couldn't find any data for rheumatoid arthritis).I got a factor of 60 last time I did the MS vs ME calculation: $5m vs $115m annually, 4 MS patients to every 10 ME patients.
Given that the IOM report suggests a higher prevalence of ME that factor of 60 might be more like 100 or 150.